Buckeyes I agree that it gives better leverage with BPs if you can show ability to go it alone.  Additionally, Don has talked before about selling a Zenith royalty to a third party (in the Middle East) to fund RVX.  A purchaser would likely want to see meaningful means to sales channels in place from a small biotech before paying up for a royalty. Gotta have sales to earn royalties!!